{
  "data": {
    "indicator": {
      "slug": "pharmaceutical-and-life-sciences-r-d-facility-investment",
      "name": "Pharmaceutical and life sciences R&D facility investment",
      "definition": "Total capital investment planned or committed to pharmaceutical and life sciences research and development facilities.",
      "unit": "GBP",
      "scale": "million",
      "default_unit": "GBP",
      "default_scale": "million"
    },
    "scale": "million",
    "unit": "GBP",
    "region": {
      "code": "GB",
      "name": "United Kingdom",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2026-07-28",
        "period_label": "as of 28 Jul 2026",
        "value": 400,
        "scale": "million",
        "unit": "GBP",
        "value_type": "estimate",
        "statistic_id": "stat_TV42FRJC8C1W7RGT6S3KBRANNY",
        "url": "https://statorigin.org/stat/stat_TV42FRJC8C1W7RGT6S3KBRANNY",
        "source_org": "GSK",
        "source": {
          "org": "GSK",
          "org_short_name": "GSK",
          "document_title": "GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK",
          "document_url": "https://www.gsk.com/en-gb/media/press-releases/gsk-to-establish-new-flagship-rd-centre-on-cambridge-biomedical-campus-uk/",
          "locator": "GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GB"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}